Flex Biomedical develops treatments for orthopedic diseases and offers Flex Polymer, a synthetic polymer designed to treat osteoarthritis.
Flex Biomedical, a Madison-based company founded in 2007, is developing innovative treatments for orthopedic diseases. The company's lead product, the Flex Polymer™, is a synthetic polymer designed to treat osteoarthritis, an incurable, debilitating joint disease that affects 27 million people in the United States and 100 million people worldwide.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2012 | Series Unknown | $881.66K | 1 |
NEW Capital Fund
|
— | Detail |
| Aug 14, 2009 | Series Unknown | $0.98M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
NEW Capital Fund
|
Yes | Series Unknown |